CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 80 filers reported holding CATALYST BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,297,000 | -10.9% | 301,678 | +21.6% | 0.62% | -1.3% |
| Q2 2020 | $1,456,000 | -13.0% | 248,050 | -35.2% | 0.62% | -20.1% |
| Q1 2020 | $1,673,000 | -37.3% | 382,900 | -2.3% | 0.78% | -33.3% |
| Q4 2019 | $2,669,000 | -2.6% | 391,894 | -29.8% | 1.17% | -22.9% |
| Q3 2019 | $2,741,000 | -32.0% | 558,159 | +2.0% | 1.52% | -25.2% |
| Q2 2019 | $4,032,000 | +2.7% | 547,092 | +13.0% | 2.03% | +18.3% |
| Q1 2019 | $3,927,000 | +6.6% | 484,200 | +3.7% | 1.72% | -9.7% |
| Q4 2018 | $3,684,000 | +44.5% | 466,900 | +97.4% | 1.90% | +33.8% |
| Q3 2018 | $2,550,000 | – | 236,558 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
| 22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
| Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
| Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
| Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
| AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
| Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
| Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |